MIGLIACCIO, Antimo
 Distribuzione geografica
Continente #
NA - Nord America 3.485
EU - Europa 3.282
AS - Asia 874
SA - Sud America 6
AF - Africa 5
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.658
Nazione #
US - Stati Uniti d'America 3.467
IE - Irlanda 1.012
IT - Italia 671
UA - Ucraina 476
GB - Regno Unito 401
CN - Cina 295
TR - Turchia 283
DE - Germania 247
SG - Singapore 245
FI - Finlandia 132
SE - Svezia 118
GR - Grecia 80
FR - Francia 71
BE - Belgio 43
KR - Corea 18
CA - Canada 13
IN - India 8
NL - Olanda 8
IR - Iran 6
AT - Austria 5
PK - Pakistan 4
VN - Vietnam 4
AR - Argentina 3
CZ - Repubblica Ceca 3
EG - Egitto 3
HU - Ungheria 3
PA - Panama 3
TH - Thailandia 3
AU - Australia 2
BR - Brasile 2
DZ - Algeria 2
ES - Italia 2
HR - Croazia 2
JO - Giordania 2
JP - Giappone 2
MK - Macedonia 2
MX - Messico 2
NZ - Nuova Zelanda 2
PL - Polonia 2
PT - Portogallo 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BD - Bangladesh 1
CL - Cile 1
EE - Estonia 1
EU - Europa 1
PH - Filippine 1
RS - Serbia 1
SA - Arabia Saudita 1
TW - Taiwan 1
Totale 7.658
Città #
Dublin 1.005
Jacksonville 736
Chandler 713
Ann Arbor 206
Singapore 167
Santa Clara 161
Princeton 143
Caserta 129
Naples 115
Medford 108
Boardman 105
Roxbury 87
Beijing 85
Wilmington 82
Istanbul 80
Bremen 75
Woodbridge 73
San Mateo 60
Ashburn 50
Nanjing 44
Brussels 43
Cambridge 37
Houston 30
Mountain View 28
Rome 28
Jinan 25
Napoli 25
Des Moines 21
Pozzuoli 21
Los Angeles 20
Nanchang 20
Shenyang 20
Norwalk 17
Aversa 16
Kunming 15
New York 13
Marano 11
Frattamaggiore 10
Seattle 10
Somma Vesuviana 10
Helsinki 9
Zhengzhou 9
Hanover 8
Salerno 8
Tricesimo 8
Düsseldorf 7
Guangzhou 7
Seoul 7
Volla 7
Afragola 6
Auburn Hills 6
Catanzaro 6
Tianjin 6
Lanzhou 5
Lappeenranta 5
Munich 5
San Marco Evangelista 5
Vienna 5
West Babylon 5
Amsterdam 4
Cercola 4
Dearborn 4
Dong Ket 4
Gunzenhausen 4
Hangzhou 4
Hebei 4
Ningbo 4
Paris 4
Perugia 4
Pune 4
Redwood City 4
Taizhou 4
Zanjan 4
Amalfi 3
Atlanta 3
Benevento 3
Budapest 3
Campobasso 3
Cesena 3
Changsha 3
Edinburgh 3
Elora 3
Ercolano 3
Giugliano in Campania 3
Haikou 3
Mazara Del Vallo 3
Milan 3
Nuremberg 3
Panama City 3
Porto Cesareo 3
Puxian 3
Quartu Sant'elena 3
Shanghai 3
Vancouver 3
Agugliano 2
Albenga 2
Amman 2
Aswan 2
Athens 2
Bangkok 2
Totale 4.899
Nome #
Bisphenol A induces cell cycle arrest in primary and prostate cancer cells through EGFR/ERK/p53 signaling pathway activation. 138
Inhibition of p110δ PI3K prevents inflammatory response and restenosis after artery injury. 105
Recent advances on bisphenol-A and endocrine disruptor effects on human prostate cancer 104
CROSS-TALK BETWEEN ANDROGEN RECEPTOR AND NERVE GROWTH FACTOR RECEPTOR IN PROSTATE CANCER CELLS: IMPLICATIONS FOR A NEW THERAPEUTIC APPROACH. 92
Breast cancer stem cells: The role of sex steroid receptors 91
Calmodulin-stimulated estradiol receptor-tyrosine kinase I 89
'Role of PI3-K signaling in steroid action’ 88
A 67 kDa non-hormone binding estradiol receptor is present in human mammary cancers 86
Phosphoinositide 3-kinase assay in breast cancer cell extracts. 86
Androgen-induced cell migration: role of androgen receptor/filamin A association. 83
Role of atypical protein kinase C in estradiol-triggered G1/S progression of MCF-7 cells 82
Protein tyrosine phosphorylation and estradiol action 81
THE DUAL ROLE OF ANDROGEN RECEPTOR IN MESENCHYMAL CELLS. 80
Role of non-genomic androgen signalling in suppressing proliferation of fibroblasts and fibrosarcoma cells. 80
Inhibition of the SH3 domain-mediated binding of Src to the androgen receptor and its effect on tumor growth 78
Analysis of androgen receptor rapid actions in cellular signaling pathways: receptor/src association 77
Targeting rapid action of sex-steroid receptors in breast and prostate cancers. 77
Estradiol activation of human colon carcinoma-derived Caco-2 cell growth 75
Androgen-stimulated DNA synthesis and cytoskeletal changes in fibroblasts by a nontranscriptional receptor action. 75
Crosstalk between EGFR and extranuclear steroid receptors. 74
Androgen regulation of motility in fibroblasts 74
Epigenetic drugs against cancer: an evolving landscape. 73
Estrogens Modulate Somatostatin Receptors Expression and Synergizes With the Somatostatin Analog Pasireotide in Prostate Cells 73
Integrating signals between cAMP and MAPK pathways in breast cancer 71
CROSS TALK BETWEEN ANDROGEN RECEPTOR/ FILAMIN A AND TrkA REGULATES NEURITE OUTGROWTH IN PC12 CELLS 71
EXTRA-NUCLEAR PARTNERS OF ANDROGEN RECEPTOR: AT THE CROSSROADS OF PROLIFERATION, MIGRATION AND NEURITOGENESIS. 70
Polyproline and Tat transduction peptides in the study of the rapid actions of steroid receptors 69
Advances in Rapid Sex-Steroid Action New Challenges and New Chances in Breast and Prostate Cancers 68
Phosphorylation on tyrosine of oestradiol-17 beta receptor in uterus and interaction of oestradiol-17 beta and glucocorticoid receptors with antiphosphotyrosine antibodies 67
PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells. 67
Estrogen Receptors in Epithelial-Mesenchymal Transition of Prostate Cancer. 67
Sex steroid hormones act as growth factors 66
Activation of the Src/Ras/Erks pathway is required for steroid-induced S-phase entry of human mammary carcinoma-derived cells 66
Steroid signaling activation and intracellular localization of sex steroid receptors 65
Binary switch between adjacent marks in histone H3 directs productive transcription in estrogen-induced breast cancer cells upon cyclical creation of ROS. 64
Phosphorylation of H3 serine 10 by IKKα governs cyclical production of ROS in estrogen-induced transcription and ensures DNA wholeness. 63
Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor. 63
The role of androgen receptor/filamin A association in androgen-induced cell migration 62
Rapid signalling pathway activation by androgens in epithelial and stromal cells 60
Activation-inactivation of hormone binding sites of the oestradiol-17 beta receptor is a multiregulated process 60
Targeting androgen receptor/Src complex impairs the aggressive phenotype of human fibrosarcoma cells. 60
Cell proliferation regulated by estradiol receptor: therapeutic implications. 59
Cross talk between epidermal growth factor (EGF) receptor and extra nuclear steroid receptors in cell lines. 59
Androgens Induce Invasiveness of Triple Negative Breast Cancer Cells through AR/Src/PI3-K Complex Assembly. 59
Steroid induced androgen receptor-oestardiol receptor ß- Src complex triggers prostate cancer cell proliferation 58
Action of vanadate on estrogen dependent MCF-7 cells. 58
Inhibition of estradiol receptor/Src association and cell growth by an estradiol receptor a alpha tyrosine-phosphorylated peptide 57
Activation of c-src/p21ras/erks pathway by steroids and its role in human mammary cancer cell lines. 57
'Steroid-activated PI3-K pathway in target cells'. 57
BRD9 binds cell type-specific chromatin regions regulating leukemic cell survival via STAT5 inhibition 57
Src is an initial target of sex steroid hormone action. 56
Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol receptor complex in MCF-7 cells 56
Novel aspects of signalling activation by steroid hormones in target cells. 56
Inhibitors targeting the Src/Ras/Erks pathway prevent cancer cell S-phase entry induced by steroids. 56
Tyrosine phosphorylation of estradiol receptor by Src regulates its hormone-dependent nuclear export and cell cycle progression in breast cancer cells. 56
The HDAC inhibitor SAHA regulates CBX2 stability via a SUMO-triggered ubiquitin-mediated pathway in leukemia 56
Prostate cancer stem cells: the role of androgen and estrogen receptors. 55
Analysis of histone posttranslational modifications in the control of chromatin plasticity observed at estrogen-responsive sites in human breast cancer cells. 54
Control of cell proliferation by estradiol and protein tyrosine phosphorilation. 54
Two domains of the progesterone receptor interact with the estrogen receptor and are required for progesterone activation of the c-Src/Erk pathway in mammalian cells 53
Direct evidence of in vitro phosphorylation-dephosphorylation of the estradiol-17 beta receptor. Role of Ca2+-calmodulin in the activation of hormone binding sites 53
Activation of Src/Ras/Erks sgnalling pathway is required for steroid-induced DNA synthesis 53
Non-genomic action of steroid hormones: More questions than answers 53
The androgen receptor/filamin A complex as a target in prostate cancer microenvironment. 53
Phosphorylation on tyrosine of in vitro synthesized human estrogen receptor activates its hormone binding 52
Steroid receptor regulation of epidermal growth factor signaling through Src in breast and prostate cancer cells: steroid antagonist action. 52
Calmodulin-stimulated phosphorylation of 17 beta-estradiol receptor on tyrosine 52
ATP-dependent enzyme activating hormone binding of estradiol receptor 51
NON-GENOMIC ANDROGEN ACTION REGULATES PROLIFERATIVE/MIGRATORY SIGNALLING IN STROMAL CELLS. 51
ICI 164,384 e ICI 182,780 prevengono l’atività proliferativa del recettore dell’estradiolo mediata dalla fosforilazione delle proteine. 51
Protein tyrosine phosphorylation and estradiol action 51
Dephosphorylation of oestradiol nuclear receptor in vitro. A hypothesis on the mechanism of action of non-steroidal anti-oestrogens 50
The role of androgen receptor in stromal cells. 50
The androgen receptor in breast cancer 50
Epidermal growth factor induces protein tyrosine phosphorylation and association of p190 with ras-GTP-ase activating protein in Caco-2 cells. 49
In vitro phosphorylation and hormone binding activation of the synthetic wild type human estradiol receptor 49
Steroid activation of signal transducing pathways. 49
The role of atypical PKC in estradiol-regulated G1/S progression of human breast cancer cells 48
Nerve Growth Factor Induces Proliferation and Aggressiveness In Prostate Cancer Cells. 48
ERβ in Triple-Negative Breast Cancer: Emerging Concepts and Therapeutic Possibilities 48
Phosphorylation of uterus estradiol receptor on tyrosine 46
The role of estradiol receptor in the proliferative activity of vanadate on MCF-7 cells 46
Steroid receptor regulation of epidermal growth factor signaling in breast and prostate cancer cells 46
P491 THE ANDROGEN RECEPTOR IN HUMAN SKELETAL MUSCLE BIOPSIES 46
Oestradiol stimulates tyrosine phosphorylation and hormone binding activity of its own receptor in a cell-free system 45
Evidence that in vivo estradiol receptor translocated into nuclei is dephosphorylated and released into cytoplasm 45
Phosphorylation of estradiol receptor on tyrosine and interaction of estradiol and glucocorticoid receptors with antiphosphotyrosine antibodies 45
PI3-K in concert with Src induces S-phase entry of an oestradiol-stimulated human breast cancer cell line 45
ANTI-ANDROGEN PEPTIDES AND USES THEREOF IN CANCER THERAPY 45
New insights and emerging therapeutic approaches in prostate cancer. 45
Nuclear receptor-induced transcription is driven by spatially and timely restricted waves of ROS: the role of Akt, IKKα and DNA damage repair enzymes. 44
Estradiol receptor: phosphorylation on tyrosine in uterus and interaction with anti-phosphotyrosine antibody 44
Non-transcriptional action of oestradiol and progestin triggers DNA synthesis. 44
Inactivation of oestrogen receptor in vitro by nuclear dephosphorylation 44
In vitro inactivation of oestrogen receptor by nuclei: prevention by phosphatase inhibitors 44
Phosphorylation of calf uterus 17 beta-estradiol receptor by endogenous Ca2+-stimulated kinase activating the hormone binding of the receptor 44
Hormone-dependent nuclear export of estradiol receptor and DNA synthesis in breast cancer cells 44
New molecules in the study of the rapid actions of steroid receptors. 44
Properties of a purified estradiol-dependent calf uterus tyrosine kinase 43
Interaction of steroid receptors with monoclonal antiphosphotyrosine antibody. 43
Totale 6.118
Categoria #
all - tutte 33.524
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.524


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020526 0 0 0 0 138 23 165 38 66 41 44 11
2020/20211.095 92 9 126 103 160 4 143 124 41 149 116 28
2021/20221.035 71 11 13 30 338 36 27 28 33 90 88 270
2022/20232.327 160 65 36 242 230 232 10 173 1.044 25 60 50
2023/2024964 102 40 29 61 278 51 47 55 13 50 101 137
2024/2025433 18 25 33 142 215 0 0 0 0 0 0 0
Totale 8.015